HRL
33
-12
DHR
56
9
MMM
73
2
EMR
56
-3
ACN
56
2
IR
71
-4
CHRW
71
-2
AFL
42
-3
ADM
40
-2
AIZ
56
-12
OI
54
4
MAS
64
-2
WEC
70
3
FOX
66
-4
PBI
49
-4
FIS
72
2
COP
39
-5
APA
48
-2
AMGN
30
2
AON
56
2
HRL
33
-12
DHR
56
9
MMM
73
2
EMR
56
-3
ACN
56
2
IR
71
-4
CHRW
71
-2
AFL
42
-3
ADM
40
-2
AIZ
56
-12
OI
54
4
MAS
64
-2
WEC
70
3
FOX
66
-4
PBI
49
-4
FIS
72
2
COP
39
-5
APA
48
-2
AMGN
30
2
AON
56
2
Financhill
Back

Mirum Pharmaceuticals 10K Form

Sell
49

MIRM
Mirum Pharmaceuticals

Last Price:
$45.28
Seasonality Move:
23.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MIRM News And Ratings

See the #1 stock for the next 7 days that we like better than MIRM

MIRM Financial Statistics

Sales & Book Value

Annual Sales: $336.9M
Cash Flow: $-2M
Price / Cash Flow: 0
Annual Sales: $4.72
Price / Book: 9.53

Profitability

EPS (TTM): -1.61220
Net Income (TTM): $-77.3M
Gross Margin: $255.2M
Return on Equity: -33.5%
Return on Assets: -11.57%

Mirum Pharmaceuticals Earnings Forecast

Key Mirum Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 5 years for MIRM is 75.77%.
  • The Selling, General & Administrative Expenses for MIRM have been equal to 60.03% of Gross Profit Margin.
  • The Research & Development expenses have been 41.74% of Revenue.
  • The Net Earning history of MIRM is -26.10% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 4 years.

Mirum Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MIRM
CUSIP: 604749
Website: mirumpharma.com

Debt

Debt-to-Equity Ratio: 1.32
Current Ratio: 3.22
Quick Ratio: 2.93

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 52.26

MIRM Technical Analysis vs Fundamental Analysis

Sell
49
Mirum Pharmaceuticals (MIRM) is a Sell

Is Mirum Pharmaceuticals a Buy or a Sell?